Investors have sharply different responses to UnitedHealth Group’s ongoing legal, regulatory and financial turmoil.

At roughly 12 times trailing adjusted earnings versus a three-year average of 25 times, a climb from around $300 to above ...

UnitedHealth Group’s multibillion-dollar pharmacy benefit manager, Optum Rx, is suing five Kentucky counties in an attempt to ...

More than 15 years ago, hedge fund manager David Tepper pulled in a $7 billion profit by backing Bank of America and Citigroup in the midst of the ...

ASML expects to generate revenue between 44 billion euros ($52 billion) and 60 billion euros ($70 billion) by 2030. The high ...

Health insurance regulators in Delaware and New Mexico have approved steep rate increases for 2025 individual market plans, ...

A new study finds the majority of home health markets in the United States are highly concentrated and controlled by only one ...

A patient-centric ecosystem means your medical information follows you and every innovation starts with the question: How ...

HQH offers a 12.4% yield and trades at a discount, with Berkshire's healthcare move signaling a sector rebound and strong ...

Many Wall Street funds and billionaires recently reported their stock holdings, as required, at the end of the second quarter ...

DaVita, which operates more than 2,600 outpatient dialysis centers across the country, said it first discovered the cyber ...

UnitedHealth stock gets a Hold rating amid valuation appeal but concerns over FY 2025 guidance & DOJ scrutiny. Read why ...